0001349929-16-000087.txt : 20160526
0001349929-16-000087.hdr.sgml : 20160526
20160526171746
ACCESSION NUMBER: 0001349929-16-000087
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150826
FILED AS OF DATE: 20160526
DATE AS OF CHANGE: 20160526
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CANCER GENETICS, INC
CENTRAL INDEX KEY: 0001349929
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 043462475
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 ROUTE 17 NORTH
STREET 2: 2ND FLOOR
CITY: RUTHERFORD
STATE: NJ
ZIP: 07070
BUSINESS PHONE: 201.528.9200
MAIL ADDRESS:
STREET 1: 201 ROUTE 17 NORTH
STREET 2: 2ND FLOOR
CITY: RUTHERFORD
STATE: NJ
ZIP: 07070
FORMER COMPANY:
FORMER CONFORMED NAME: CANCER GENETICS INC
DATE OF NAME CHANGE: 20060117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAPPAJOHN JOHN
CENTRAL INDEX KEY: 0000897464
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35817
FILM NUMBER: 161679193
MAIL ADDRESS:
STREET 1: 1660 WALT WHITMAN ROAD
STREET 2: SUITE 105
CITY: MELVILLE
STATE: NY
ZIP: 11747
4/A
1
wf-form4a_146429745321843.xml
FORM 4/A
X0306
4/A
2015-08-26
2015-08-27
0
0001349929
CANCER GENETICS, INC
CGIX
0000897464
PAPPAJOHN JOHN
201 ROUTE 17 NORTH
2ND FLOOR
RUTHERFORD
NJ
07070
1
0
1
0
Common Stock, par value $0.0001 per share
2015-08-26
4
P
0
2500
8.9744
A
1521789
D
Common Stock, par value $0.0001 per share
2015-08-27
4
P
0
2500
10.2496
A
1524289
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.920 to $9.00, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.24 to $10.25, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
The total number of shares reported has been increased by 5,000 shares due to prior inadvertent under-reporting of the total number of shares beneficially owned by the reporting person.
/s/ John Pappajohn by Edward J Sitar as Attorney-in-fact
2016-05-25